IGF1 and Alzheimer disease: Additionally, the hippocampal formation and the cerebellar cortex of non-diabetic human AD brains show decreased responses to insulin and IGF-1 signaling (i.e., IR/IGF-1 resistance) and elevated basal levels of serine phosphorylated IRS-1, as measured by ex vivo stimulation [73].